{"id":"NCT02194699","sponsor":"AstraZeneca","briefTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma","officialTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-30","primaryCompletion":"2017-05-10","completion":"2017-09-21","firstPosted":"2014-07-18","resultsPosted":"2018-03-21","lastUpdate":"2018-05-15"},"enrollment":856,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Uncontrolled Asthma"],"interventions":[{"type":"BIOLOGICAL","name":"Experimental: Tralokinumab","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tralokinumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist","primaryOutcome":{"measure":"Annualised Asthma Exacerbation Rate (AAER) up to Week 52","timeFrame":"Baseline (Week 0) up to Week 52","effectByArm":[{"arm":"Biomarker Positive - Tralo 300 mg Q2W","deltaMin":0.8,"sd":null},{"arm":"Biomarker Positive - Placebo","deltaMin":0.95,"sd":null},{"arm":"Biomarker Negative - Tralo 300 mg Q2W","deltaMin":0.87,"sd":null},{"arm":"Biomarker Negative - Placebo","deltaMin":0.77,"sd":null},{"arm":"Tralo 300 mg Q2W","deltaMin":0.84,"sd":null},{"arm":"Placebo","deltaMin":0.82,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.4656"},{"comp":"OG002 vs OG003","p":"0.4126"},{"comp":"OG000 vs OG001","p":"0.4656"},{"comp":"OG004 vs OG005","p":"0.8027"},{"comp":"OG004 vs OG005","p":"0.8027"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":234,"countries":["United States","Canada","Chile","Czechia","Italy","Japan","Mexico","Philippines","Russia","South Africa","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["31315668","30649752","29792288","29536781"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":425},"commonTop":["Viral upper respiratory tract infection","Asthma","Headache","Bronchitis","Upper respiratory tract infection"]}}